ESCRS - Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W ;
Supplements

Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W

Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W

This supplement shares technical tips on taking the first step with iStent inject® W, improving the benefit to risk ratio, and improving quality of life on the glaucoma journey.

Tags: glaucoma
Latest Articles
Which Farsighted Fix?

Evolving technologies opening new doors to best treatments.

Read more...

A New High for Hyperopia

Hyperopia patients can expect a rise in the array of treatments.

Read more...

Research Committee is Engine Driving the Future of ESCRS

Commitment to evidence-based medicine anchors studies and other projects.

Read more...

ESCRS EPICAT Study Updates

Early results suggest subconjunctival 10 mg triamcinolone an effective strategy for dropless cataract surgery.

Read more...

Fit for Duty

One surgeon’s tale of rising above stress.

Read more...

Second Global Consensus on Keratoconus

Forthcoming position paper to provide an updated and expanded view on evaluation and management.

Read more...

Automating Cataract Surgery Assessment

AI system measures eye stability and centration in procedures.

Read more...

Post-LASIK Tonometer Takes ESCRS Innovators Den Prize

Good ideas lead to solutions to unmet needs.

Read more...

ESCRS forms Functional Vision Working Group

Read more...

Expanding the Limits of KLEx

Hyperopia treatment receives CE approval; mixed astigmatism may follow.

Read more...